Hims & Hers Health (HIMS) Current Deferred Revenue (2020 - 2026)

Hims & Hers Health has reported Current Deferred Revenue for 7 years, with the latest figure at $165.1 million in Q1 2026.

• Quarterly Current Deferred Revenue rose 49.05% year-over-year to $165.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $165.1 million (up 49.05% YoY) and the FY2025 annual result came in at $127.2 million, up 68.87% from the prior year.
• Current Deferred Revenue rose to $165.1 million in Q1 2026 per HIMS's latest filing, from $127.2 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $165.1 million in Q1 2026 and troughed at $1.1 million in Q1 2022.
• A 5-year average of $46.2 million and a median of $13.7 million in 2024 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2022 and 2024: Current Deferred Revenue plunged 53.83% in 2022, then jumped 919.92% in 2024.
• Over 5 years, Current Deferred Revenue stood at $1.5 million in 2022, then surged by 425.34% to $7.7 million in 2023, then jumped by 873.75% to $75.3 million in 2024, then soared by 68.87% to $127.2 million in 2025, then climbed by 29.84% to $165.1 million in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $165.1 million, $127.2 million, and $118.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.